Alignment Healthcare (ALHC) stock: insider trades, news & valuation
Net selling
Close · Oct 9, 2026
$7.54
-13.4% on the day
-57.0% over 12 months
52-week range $7.54 – $24.56
Share price and insider trades
ALHC closeInsider buyInsider sale
Bought, 12 months$198K
Sold, 12 months$526M
Insiders buying1
Insiders selling11
Alignment Healthcare insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $198K and 11 sold $526M of ALHC stock on the open market.
Get emailed when insiders cluster-buy stocks like ALHC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
ALHC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $270K | 1 |
| Q3 2026 | — | 0 | $23.7M | 11 |
| Q2 2026 | $198K | 1 | $27.1M | 18 |
| Q1 2026 | — | 0 | $28.0M | 29 |
| Q4 2025 | — | 0 | $447M | 24 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.6×Last 5 sessions
Insiders' paper profit−$86KOn all tracked purchases -43.3%
Summary
Over the past 12 months, 1 Alignment Healthcare, Inc. insider reported open-market purchases totaling $198K, while 11 insiders reported sales totaling $526M. 52 of 83 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
ALHC earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Jul 30, 2026 | -13.7% | Sold $10.2M | -18.8%S&P +2.4% | -8.3% |
| Apr 30, 2026 | +2.1% | Sold $12.6M | -6.7%S&P +1.3% | -24.4% |
| Feb 26, 2026 | -2.4% | Sold $4.8M | -4.5%S&P -1.0% | -13.5% |
| Oct 30, 2025 | +5.5% | Sold $5.0M | -7.4%S&P -0.8% | +13.9% |
| Jul 30, 2025 | -12.1% | None | +17.0%S&P -0.5% | +18.7% |
| May 1, 2025 | -8.8% | None | -12.4%S&P +2.2% | -1.0% |
| Feb 27, 2025 | -8.5% | None | +19.2%S&P -0.1% | +16.6% |
| Oct 29, 2024 | +0.8% | None | +1.6%S&P -0.1% | +7.5% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 7SEC | Hyong KimChief Medical Officer | Sell | 32,479299,271 held (−10%) | $8.30 | $270K | -9.1% | — |
| Sep 18SEC | Joseph S KonowieckiEvp, Corporate Affairs | Sell | 23,5111,080,305 held (−2%) | $8.61 | $202K | -12.4% | — |
| Sep 16SEC | John E KaoCEO | Sell Plan | 27,400590,766 held (−4%) | $13.00 | $356K | -42.0% | — |
| Sep 11SEC | John E KaoCEO | Sell Plan | 385,2701,223,473 held (−24%) | $12.68 | $4.9M | -40.5% | — |
| Sep 11SEC | John E KaoCEO | Sell Plan | 172,600618,166 held (−22%) | $12.96 | $2.2M | -41.8% | — |
| Sep 11SEC | Dawn Christine MaroneyPresident | Sell | 122,707794,606 held (−13%) | $12.68 | $1.6M | -40.5% | — |
| Aug 18SEC | Dawn Christine MaroneyPresident | Sell Plan | 5,000917,313 held (−1%) | $14.00 | $70K | -46.1% | — |
| Aug 10SEC | John E KaoCEO | Sell Plan | 298,000790,766 held (−27%) | $13.88 | $4.1M | -45.6% | — |
| Jul 16SEC | Dawn Christine MaroneyPresident | Sell Plan | 177,068922,313 held (−16%) | $20.83 | $3.7M | -63.8% | — |
| Jul 14SEC | John E KaoCEO | Sell Plan | 279,6441,107,122 held (−20%) | $19.81 | $5.5M | -61.9% | — |
| Jul 14SEC | John E KaoCEO | Sell Plan | 18,3561,088,766 held (−2%) | $20.65 | $379K | -63.5% | — |
| Jul 1SEC | Joseph S KonowieckiEvp, Corporate Affairs | Sell Plan | 25,0001,103,816 held (−2%) | $24.00 | $600K | -68.6% | — |
| Jun 26SEC | Joseph S KonowieckiEvp, Corporate Affairs | Sell Plan | 25,0001,128,816 held (−2%) | $23.00 | $575K | -67.2% | — |
| Jun 18SEC | Joseph S KonowieckiEvp, Corporate Affairs | Sell Plan | 25,0001,153,816 held (−2%) | $22.00 | $550K | -65.7% | — |
| Jun 15SEC | Hyong KimChief Medical Officer | Sell Plan | 35,951331,750 held (−10%) | $19.86 | $714K | -62.0% | — |
| Jun 15SEC | Dawn Christine MaroneyPresident | Sell Plan | 30,000947,313 held (−3%) | $19.55 | $586K | -61.4% | — |
| Jun 12SEC | John E KaoCEO | Sell Plan | 223,0641,386,766 held (−14%) | $20.60 | $4.6M | -63.4% | — |
| Jun 12SEC | John E KaoCEO | Sell Plan | 74,9361,609,830 held (−4%) | $19.65 | $1.5M | -61.6% | — |
| Jun 12SEC | Joseph S KonowieckiEvp, Corporate Affairs | Sell Plan | 25,0001,178,816 held (−2%) | $21.00 | $525K | -64.1% | — |
| Jun 2SEC | Mark D. KentPresident | Buy | 14,848new position | $13.31 | $198K | -43.3% | — |
| May 19SEC | Dawn Christine MaroneyPresident | Sell Plan | 30,000998,813 held (−3%) | $16.09 | $483K | -53.1% | — |
| May 13SEC | John E KaoCEO | Sell Plan | 280,8931,525,748 held (−16%) | $16.85 | $4.7M | -55.2% | — |
| May 13SEC | John E KaoCEO | Sell Plan | 17,1071,508,641 held (−1%) | $17.54 | $300K | -57.0% | — |
| Apr 15SEC | Dawn Christine MaroneyPresident | Sell Plan | 30,0001,028,813 held (−3%) | $20.87 | $626K | -63.8% | — |
| Apr 13SEC | John E KaoCEO | Sell Plan | 201,9001,902,741 held (−10%) | $20.58 | $4.2M | -63.3% | — |
| Apr 13SEC | John E KaoCEO | Sell Plan | 82,2991,806,641 held (−4%) | $20.80 | $1.7M | -63.7% | — |
| Apr 13SEC | John E KaoCEO | Sell Plan | 13,8011,888,940 held (−1%) | $21.38 | $295K | -64.7% | — |
| Apr 8SEC | John E KaoCEO | Sell Plan | 132,2412,222,400 held (−6%) | $20.67 | $2.7M | -63.5% | — |
| Apr 8SEC | John E KaoCEO | Sell Plan | 117,7592,104,641 held (−5%) | $21.40 | $2.5M | -64.7% | — |
| Apr 8SEC | James M HeadCFO | Sell | 11,100173,495 held (−6%) | $21.08 | $234K | -64.2% | — |
| Apr 1SEC | Christopher J JoyceGeneral Counsel | Sell Plan | 18,013305,451 held (−6%) | $17.79 | $320K | -57.6% | — |
| Mar 23SEC | John E KaoCEO | Sell Plan | 118,0002,354,641 held (−5%) | $17.48 | $2.1M | -56.8% | — |
| Mar 19SEC | John E KaoCEO | Sell | 73,0461,784,868 held (−4%) | $17.84 | $1.3M | -57.7% | — |
| Mar 19SEC | Dawn Christine MaroneyPresident | Sell | 36,7491,058,813 held (−3%) | $17.84 | $656K | -57.7% | — |
| Mar 19SEC | Christopher J JoyceGeneral Counsel | Sell | 25,125323,464 held (−7%) | $17.84 | $448K | -57.7% | — |
| Mar 19SEC | Hyong KimChief Medical Officer | Sell | 18,404367,701 held (−5%) | $17.84 | $328K | -57.7% | — |
| Mar 19SEC | Sebastian BurzacchiCOO | Sell | 15,361258,630 held (−6%) | $17.84 | $274K | -57.7% | — |
| Mar 19SEC | Andreas P. WagnerChief Human Resources Officer | Sell Plan | 12,000160,230 held (−7%) | $17.84 | $214K | -57.7% | — |
| Mar 19SEC | Andreas P. WagnerChief Human Resources Officer | Sell Plan | 11,602148,628 held (−7%) | $18.22 | $211K | -58.6% | — |
| Mar 19SEC | Robert L. ScavoChief Information Officer | Sell | 11,285487,685 held (−2%) | $17.84 | $201K | -57.7% | — |
| Mar 17SEC | Dawn Christine MaroneyPresident | Sell Plan | 30,0001,095,562 held (−3%) | $17.48 | $524K | -56.8% | — |
| Mar 13SEC | John E KaoCEO | Sell | 45,9381,522,441 held (−3%) | $17.48 | $803K | -56.8% | — |
| Mar 13SEC | Dawn Christine MaroneyPresident | Sell | 27,350965,465 held (−3%) | $17.48 | $478K | -56.8% | — |
| Mar 13SEC | Robert L. ScavoChief Information Officer | Sell | 3,799499,215 held (−1%) | $17.48 | $66K | -56.8% | — |
| Mar 13SEC | John E KaoCEO | Sell | 2,9611,519,480 held (−0%) | $16.99 | $50K | -55.6% | — |
| Mar 13SEC | Dawn Christine MaroneyPresident | Sell | 1,763963,702 held (−0%) | $16.99 | $30K | -55.6% | — |
| Mar 13SEC | Robert L. ScavoChief Information Officer | Sell | 245498,970 held (−0%) | $16.99 | $4K | -55.6% | — |
| Mar 10SEC | John E KaoCEO | Sell Plan | 180,0002,472,641 held (−7%) | $18.19 | $3.3M | -58.5% | — |
| Mar 4SEC | Andreas P. WagnerChief Human Resources Officer | Sell Plan | 21,118148,687 held (−12%) | $18.62 | $393K | -59.5% | — |
| Feb 17SEC | Dawn Christine MaroneyPresident | Sell Plan | 30,000997,015 held (−3%) | $20.63 | $619K | -63.4% | — |
| Feb 10SEC | John E KaoCEO | Sell Plan | 180,0002,652,641 held (−6%) | $20.49 | $3.7M | -63.2% | — |
| Feb 10SEC | Andreas P. WagnerChief Human Resources Officer | Sell | 22,238169,805 held (−12%) | $20.47 | $455K | -63.1% | — |
| Jan 16SEC | Dawn Christine MaroneyPresident | Sell Plan | 14,8711,027,015 held (−1%) | $22.78 | $339K | -66.9% | — |
| Jan 16SEC | Dawn Christine MaroneyPresident | Sell Plan | 15,1291,041,886 held (−1%) | $22.19 | $336K | -66.0% | — |
| Jan 14SEC | John E KaoCEO | Sell Plan | 177,2732,835,368 held (−6%) | $21.10 | $3.7M | -64.2% | — |
| Jan 14SEC | John E KaoCEO | Sell Plan | 2,7272,832,641 held (−0%) | $21.57 | $59K | -65.0% | — |
| Jan 6SEC | Dawn Christine MaroneyPresident | Sell Plan | 228,1521,057,015 held (−18%) | $21.33 | $4.9M | -64.6% | — |
| Jan 6SEC | Dawn Christine MaroneyPresident | Sell Plan | 100,0001,285,167 held (−7%) | $20.03 | $2.0M | -62.3% | — |
| Jan 6SEC | Hyong KimChief Medical Officer | Sell Plan | 16,506333,133 held (−5%) | $21.35 | $352K | -64.7% | — |
| Jan 6SEC | Christopher J JoyceGeneral Counsel | Sell Plan | 10,611297,088 held (−3%) | $20.03 | $213K | -62.3% | — |
| Dec 30SEC | John E KaoCEO | Sell | 572,4372,267,505 held (−20%) | $18.71 | $10.7M | -59.7% | — |
| Dec 30SEC | Dawn Christine MaroneyPresident | Sell | 266,6031,400,634 held (−16%) | $18.71 | $5.0M | -59.7% | — |
| Dec 30SEC | Robert L. ScavoChief Information Officer | Sell | 65,728506,827 held (−11%) | $18.71 | $1.2M | -59.7% | — |
| Dec 30SEC | John E KaoCEO | Sell | 33,2112,234,294 held (−1%) | $19.38 | $644K | -61.1% | — |
| Dec 30SEC | Dawn Christine MaroneyPresident | Sell | 15,4671,385,167 held (−1%) | $19.38 | $300K | -61.1% | — |
| Dec 30SEC | Christopher J JoyceGeneral Counsel | Sell | 15,299308,587 held (−5%) | $18.71 | $286K | -59.7% | — |
| Dec 30SEC | Hyong KimChief Medical Officer | Sell | 11,998350,335 held (−3%) | $18.71 | $224K | -59.7% | — |
| Dec 30SEC | Robert L. ScavoChief Information Officer | Sell | 3,813503,014 held (−1%) | $19.38 | $74K | -61.1% | — |
| Dec 30SEC | Christopher J JoyceGeneral Counsel | Sell | 888307,699 held (−0%) | $19.38 | $17K | -61.1% | — |
| Dec 30SEC | Hyong KimChief Medical Officer | Sell | 696349,639 held (−0%) | $19.38 | $13K | -61.1% | — |
| Dec 15SEC | Dawn Christine MaroneyPresident | Sell Plan | 113,3191,667,237 held (−6%) | $20.01 | $2.3M | -62.3% | — |
| Dec 15SEC | Dawn Christine MaroneyPresident | Sell Plan | 16,6811,780,556 held (−1%) | $20.02 | $334K | -62.3% | — |
| Dec 12SEC | Atlantic Genpar, L.p. General10% Owner | Sell | 11,119,49413,476,585 held (−45%) | $18.57 | $206M | -59.4% | — |
| Dec 12SEC | Atlantic (aln Hlth), L.p. General10% Owner | Sell | 11,119,49413,476,585 held (−45%) | $18.57 | $206M | -59.4% | — |
| Dec 12SEC | John E KaoCEO | Sell Plan | 180,0002,346,726 held (−7%) | $19.02 | $3.4M | -60.3% | — |
| Dec 12SEC | Sebastian BurzacchiCOO | Sell | 12,585237,793 held (−5%) | $19.26 | $242K | -60.8% | — |
| Dec 8SEC | Christopher J JoyceGeneral Counsel | Sell Plan | 19,706323,886 held (−6%) | $19.33 | $381K | -61.0% | — |
| Nov 26SEC | Joseph S KonowieckiDirector | Sell Plan | 25,0001,056,141 held (−2%) | $19.00 | $475K | -60.3% | — |
| Nov 12SEC | John E KaoCEO | Sell Plan | 180,0002,526,726 held (−7%) | $16.32 | $2.9M | -53.8% | — |
| Nov 12SEC | Joseph S KonowieckiDirector | Sell | 4,8321,081,141 held (−0%) | $16.49 | $80K | -54.2% | — |
| Oct 28SEC | Joseph S KonowieckiDirector | Sell Plan | 25,0001,085,973 held (−2%) | $18.00 | $450K | -58.1% | — |
| Oct 14SEC | John E KaoCEO | Sell Plan | 180,0002,706,726 held (−6%) | $17.29 | $3.1M | -56.4% | — |
| Oct 10SEC | Hyong KimChief Medical Officer | Sell Plan | 51,379362,333 held (−12%) | $17.57 | $903K | -57.1% | — |
| Oct 10SEC | Hyong KimChief Medical Officer | Sell Plan | 33,655413,712 held (−8%) | $17.29 | $582K | -56.4% | — |
Insiders at Alignment Healthcare, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Atlantic Genpar, L.p. General10% Owner | — | $206M | Dec 12, 2025 | — |
| Atlantic (aln Hlth), L.p. General10% Owner | — | $206M | Dec 12, 2025 | — |
| John E KaoCEO | — | $75.9M | Sep 16, 2026 | — |
| Dawn Christine MaroneyPresident | — | $24.7M | Sep 11, 2026 | — |
| Joseph S KonowieckiEvp, Corporate Affairs | — | $3.5M | Sep 18, 2026 | — |
| Hyong KimChief Medical Officer | — | $3.4M | Oct 7, 2026 | — |
| Christopher J JoyceGeneral Counsel | — | $1.7M | Apr 1, 2026 | — |
| Robert L. ScavoChief Information Officer | — | $1.6M | Mar 19, 2026 | — |
| Andreas P. WagnerChief Human Resources Officer | — | $1.3M | Mar 19, 2026 | — |
| Mark D. KentPresident | $198K | — | Jun 2, 2026 | — |
| Sebastian BurzacchiCOO | — | $516K | Mar 19, 2026 | — |
| James M HeadCFO | — | $234K | Apr 8, 2026 | — |
ALHC stock: common questions
Are Alignment Healthcare, Inc. insiders buying ALHC stock?
In the past 12 months, 1 insiders reported open-market purchases of ALHC worth $198K. The latest was President Mark D. Kent bought $198K of ALHC at $13.31 — first open-market purchase in our records; opens a new position.
Are Alignment Healthcare, Inc. insiders selling ALHC stock?
11 insiders reported sales worth $526M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ALHC's 52-week range?
Over the past year ALHC has traded between $7.54 and $24.56. It last closed at $7.54 on Oct 9, 2026.